gabexate has been researched along with Hypoxia in 1 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Hypoxia: Sub-optimal OXYGEN levels in the ambient air of living organisms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kabuto, T | 1 |
| Furukawa, H | 1 |
| Imaoka, S | 1 |
| Iwanaga, T | 1 |
1 other study available for gabexate and Hypoxia
| Article | Year |
|---|---|
[Therapy of postoperative hypoxia following mediastinal lymph node excision of esophageal cancer].
Topics: Aged; Animals; Dogs; Esophageal Neoplasms; Gabexate; Guanidines; Humans; Hypoxia; Lymph Node Excisio | 1987 |